IMMUNIC, INC. — Director's Dealing 2014

Dec 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2014-12-02

Reporting Person: Winters Terence E. (Director, Co-Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-02	Common Stock	J	189	$0.00	Acquired	184631	Direct
2014-12-02	Common Stock	J	745	$0.00	Acquired	185376	Direct

Footnotes

F1: Pro rata distribution from Valley Ventures III, L.P., of which the Reporting Person is a special limited partner.

F2: Pro rata distribution from Valley Ventures III Annex, L.P., of which the Reporting Person is a special limited partner.